| Literature DB >> 35655465 |
Jianfang Zhou1, Xu-Ying Luo1, Guang-Qiang Chen1, Hong-Liang Li1, Ming Xu1, Shuai Liu1, Yan-Lin Yang1, Guangzhi Shi1, Jian-Xin Zhou1, Linlin Zhang1.
Abstract
Background: Data concerning the epidemiology of sepsis in critically ill post-craniotomy patients are scarce. This study aimed to assess the incidence, risk factors, and outcomes of sepsis in this population.Entities:
Keywords: incidence; outcome; post-craniotomy; risk factor; sepsis
Mesh:
Year: 2022 PMID: 35655465 PMCID: PMC9152261 DOI: 10.3389/fpubh.2022.895991
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Figure 1Flow diagram of enrolled patients. ICU, intensive care unit; LOS, length of stay.
Demographic characteristics and outcomes of patients.
|
|
|
|
|
|
|---|---|---|---|---|
| Age (years) | 49.5 (14.6) | 52.8 (15.0) | 47.9 (14.2) | <0.001 |
| Male, | 498 (55.3%) | 194 (64.7%) | 304 (50.7%) | <0.001 |
| Smoking, | 151 (16.8%) | 58 (19.3%) | 93 (15.5%) | 0.147 |
| Alcoholism, | 91 (10.1%) | 37 (12.3%) | 54 (9.0%) | 0.118 |
| Comorbidities | ||||
| Hypertension, | 259 (28.8%) | 111 (37.0%) | 148 (24.7%) | <0.001 |
| Diabetes, | 89 (9.9%) | 38 (12.7%) | 51 (8.5%) | 0.048 |
| Cerebrovascular disease, | 71 (7.9%) | 28 (9.3%) | 43 (7.2%) | 0.256 |
| Tumor, | 42 (4.7%) | 12 (4.0%) | 30 (5.0%) | 0.503 |
| Coronary heart disease, | 35 (3.9%) | 14 (4.7%) | 21 (3.5%) | 0.393 |
| Chalson comorbidity index | 0 (0, 0) | 0 (0, 1) | 0 (0, 0) | 0.180 |
| Type of patients | 0.002 | |||
| Elective surgery, | 703 (78.1%) | 216 (72.0%) | 487 (81.2%) | |
| Emergency surgery, | 197 (21.9%) | 84 (28.0%) | 113 (18.8%) | |
| Operative time (hours) | 4.3 (3.0, 6.0) | 4.0 (2.8, 5.5) | 4.6 (3.0, 6.2) | 0.002 |
| GCS on postoperative day 1 | 10 (7, 11) | 8 (5, 10) | 10 (7, 14) | <0.001 |
| APACHE II | 16 (11, 20) | 18 (14, 23) | 14 (10, 18) | <0.001 |
| SOFA of ICU day1 | 4 (3, 6) | 5 (4,6) | 4 (2, 5) | <0.001 |
| GOS at hospital discharge | 4 (3, 5) | 3 (3,4) | 4 (3, 5) | <0.001 |
| Death, | 91 (10.1%) | 41 (13.7%) | 50 (8.3%) | 0.012 |
| ICU LOS, days | 6 (3, 13) | 14 (8,22) | 4 (3, 7) | <0.001 |
| Hospital LOS before ICU admission, days | 4 (2, 11) | 10 (4,19) | 4 (2, 7) | <0.001 |
| Total hospital LOS, days | 22 (15, 32) | 31(21,43) | 19 (14, 27) | <0.001 |
| Hospitalization costs (CNY) | 93,179 (62,590, 138,496) | 138,394 (101,060, 189,994) | 75,918 (56,297, 107,793) | <0.001 |
Data were expressed as mean and SD;
Data were expressed as median and quartiles; APACHE II, Acute Physiology and Chronic Health Evaluation II; SOFA, Sequential Organ Failure Assessment; ICU, Intensive care unit; GCS, Glasgow Coma Scale; GOS, Glasgow Outcome Scale; LOS, length of stay.
Figure 2Time of the patients diagnosed with sepsis. (A) The occurrence time of sepsis after craniotomy. (B) The occurrence time of sepsis after intensive care unit (ICU) admission.
Indications for craniotomy, surgery category, surgical site, contamination class of surgical wound, and the corresponding incidence of infection and sepsis.
|
|
|
|
|
| ||
|---|---|---|---|---|---|---|
| Indications for craniotomy | ||||||
| Tumor | 293 (57.6%) | 253 (64.7%) | 0.03 | 161 (53.7% | 385 (64.2%) | 0.002 |
| Glioma | 97 (19.1%) | 65 (16.6%) | 0.346 | 56 (18.7%) | 106 (17.7%) | 0.713 |
| Meningiomas | 68 (13.4%) | 82 (21.0%) | 0.002 | 32 (10.7%) | 118 (19.7%) | 0.001 |
| Tumors of the cranial and paraspinal nerves | 35 (6.9%) | 27 (6.9%) | 1.000 | 13 (4.3%) | 49 (8.17%) | 0.032 |
| Tumors of the sellar region | 30 (5.9%) | 26 (6.6%) | 0.642 | 25 (8.3%) | 31 (5.2%) | 0.064 |
| Mesenchymal, non-meningothelial tumors | 25 (4.9%) | 15 (3.8%) | 0.438 | 13 (4.3%) | 27 (4.5%) | 0.909 |
| Embryonal tumors | 21 (4.1%) | 18 (4.6%) | 0.727 | 10 (3.3%) | 29 (4.8%) | 0.297 |
| Metastatic tumors | 7 (1.4%) | 4 (1.0%) | 0.765 | 4 (1.3%) | 7 (1.2%) | 1 |
| Other tumors | 10 (2.0%) | 16 (4.1%) | 0.059 | 8 (2.7%) | 18 (3.0%) | 0.778 |
| Trauma | 80 (15.7%) | 22 (5.6%) | <0.001 | 53 (17.7%) | 49 (8.2%) | <0.001 |
| Cerebrovascular disease | 116 (22.8%) | 98 (25.1%) | 0.427 | 74 (24.7%) | 140 (23.3%) | 0.658 |
| Aneurysm | 52 (10.2%) | 38 (9.7%) | 0.805 | 34 (11.3%) | 56 (9.3%) | 0.346 |
| Vascular malformation | 30 (5.9%) | 28 (7.2%) | 0.443 | 18 (6.0%) | 40 (6.7%) | 0.701 |
| Intracranial hemorrhage | 24 (4.7%) | 18 (4.6%) | 0.937 | 15 (5.0%) | 27 (4.5%) | 0.737 |
| Occlusive cerebrovascular disease | 10 (2.0%) | 14 (3.6%) | 0.136 | 7 (2.3%) | 17 (2.8%) | 0.661 |
| Other indications | 20 (3.9%) | 18 (4.6%) | 0.618 | 12 (4.0%) | 26 (4.3%) | 0.815 |
| Surgery category | 0.004 | 0.002 | ||||
| Elective surgery | 380 (74.7%) | 323 (82.6%) | 216 (72.0%) | 487 (81.2%) | ||
| Emergency surgery | 129 (25.3%) | 68 (17.4%) | 84 (28.0%) | 113 (18.8%) | ||
| Surgical site | 0.186 | 0.057 | ||||
| Supratentorial | 301 (59.1%) | 214 (54.7%) | 185 (61.7%) | 330 (55.0%) | ||
| Infratentorial | 208 (40.9%) | 177 (45.3%) | 115 (38.3%) | 270 (45.0%) | ||
| Contamination class | 0.257 | 0.036 | ||||
| Clean | 456 (89.6%) | 359 (91.8%) | 263 (87.7%) | 552 (92.0%) | ||
| Clean-contaminant | 53 (10.4%) | 32 (8.2%) | 37 (12.3%) | 48 (8.0%) |
Other tumors included neuronal and mixed neuronal-glial tumor, choroid plexus tumor, lymphomas, tumors of the pineal region, melanocytic tumors and germ cell tumors;
Other indications included dysplasia diseases, functional neurological diseases, hydrocephalus and intracranial infections.
Figure 3UpSet plots depicting the distribution of infection sites in patients with (A) infection and (B) sepsis. The total numbers of patients with different sites of infections were represented on the left barplot. For patients had multi-site infections, the distributions of their infection sites were represented by the bottom plot, and the numbers of patients were shown on the top barplot. Other sources of infection and sepsis included bloodstream infection, skin and soft tissue infection, intrathoracic infection, parotiditis, osteomyelitis and upper respiratory tract infection.
Pathogens isolated from patients with infection and sepsis.
|
|
|
|
|---|---|---|
| Gram-negative bacteria | 205 (40.3%) | 161 (53.7%) |
| | 90 (17.7%) | 69 (23.0%) |
| | 58 (11.4%) | 49 (16.3%) |
| | 24 (4.7%) | 20 (6.7%) |
| | 12 (2.4%) | 10 (3.3%) |
| | 9 (1.8%) | 7 (2.3%) |
| | 8 (1.6%) | 5 (1.7%) |
| | 8 (1.6%) | 7 (2.3%) |
| Gram negative, others | 11 (2.2%) | 8 (2.7%) |
| Gram-positive bacteria | 126 (24.8%) | 86 (28.7%) |
| MRSA | 83 (16.3%) | 59 (19.7%) |
| MSSA | 14 (2.8%) | 13 (4.3%) |
| | 11 (2.2%) | 5 (1.7%) |
| Other | 13 (2.6%) | 7 (2.3%) |
| Gram positive, others | 10 (2.0%) | 7 (2.3%) |
| Other pathogens | 9 (1.8%) | 7 (2.3%) |
Other Gram negative bacteria included Burkholderia cepacia, Stenotrophomonas maltophilia, Proteus mirabilis, Citrobacter braakii and Klebsiella oxytoca;
Other Staphylococcus included Staphylococcus hominis, Staphylococcus capitis, Staphylococcus warneri and Staphylococcus saprophyticus;
Other Gram-positive bacteria included Clostridium difficile, Enterococcus faecium, Enterococcus faecalis and Streptococcus;
Other pathogens included Candida, Aspergillus and Chlamydia. MRSA, Methicillin-resistant Staphylococcus aureus; MSSA, Methicillin-sensitive Staphylococcus aureus.
Risk factors for infection and sepsis in critically ill post-craniotomy patients.
|
|
|
| ||
|---|---|---|---|---|
|
|
|
|
| |
| Age | - | - | 1.014 (1.002, 1.027) | 0.027 |
| Male | - | - | 1.739 (1.217, 2.485) | 0.002 |
| Hypertension | - | - | 1.526 (1.025, 2.274) | 0.038 |
| Trauma | 2.741 (1.275, 5.892) | 0.010 | 2.294 (1.157,4.548) | 0.017 |
| Operative time (hours) | 1.12 (1.043, 1.203) | 0.002 | - | - |
| GCS on postoperative day 1 | 0.943 (0.894, 0.995) | 0.031 | 0.819 (0.777, 0.864) | <0.001 |
| Postoperative intracranial complications | 1.785 (1.064, 2.994) | 0.028 | 2.086 (1.307, 3.330) | 0.002 |
Factors listed are those found statistically significant after Multinomial Logistic Regression analysis. Other factors entered into the model but no longer significant after adjustment included smoking, alcoholism, diabetes, categories of surgery (elective or emergency surgery), surgical sites (supratentorial or infratentorial surgery), surgical wound classifications (clean or clean-contaminated) and intracranial tumors.
Postoperative intracranial complications included intracranial hemorrhage, cerebral infarction, hydrocephalus, cerebrospinal fluid leakage and other intracranial complications. OR, Odds ratio; CI, Confidence interval; GCS, Glasgow Coma Scale.
Mortality rates of patients with different intracranial diseases, surgical categories, surgical sites, and surgical wound classifications.
|
|
|
|
| ||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||
| Indications for craniotomy | |||||||
| Tumor | |||||||
| Glioma | 162 | 6.2% | 56 | 8.9% | 106 | 4.7% | 0.316 |
| Meningiomas | 150 | 2.0% | 32 | 3.1% | 118 | 1.7% | 0.516 |
| Tumors of the cranial and paraspinal nerves | 62 | 6.5% | 13 | 7.7% | 49 | 6.1% | 1.000 |
| Tumors of the sellar region | 56 | 10.7% | 25 | 24% | 31 | 0% | 0.005 |
| Mesenchymal, non-meningothelial tumors | 40 | 5.0% | 13 | 7.7% | 27 | 3.7% | 1.000 |
| Embryonal tumors | 39 | 7.7% | 10 | 20% | 29 | 3.4% | 0.156 |
| Metastatic tumors | 11 | 18.2% | 4 | 25% | 7 | 14.3% | 1.000 |
| Other tumors | 26 | 15.4% | 8 | 25% | 18 | 11.1% | 0.563 |
| Trauma | 102 | 26.5% | 53 | 26.4% | 49 | 26.5% | 0.989 |
| Cerebrovascular disease | |||||||
| Aneurysm | 90 | 12.2% | 34 | 8.8% | 56 | 14.3% | 0.524 |
| Vascular malformation | 58 | 1.7% | 18 | 5.6% | 40 | 0% | 0.31 |
| Intracranial hemorrhage | 42 | 26.2% | 15 | 26.7% | 27 | 25.9% | 1.000 |
| Occlusive cerebrovascular disease | 24 | 20.8% | 7 | 0% | 17 | 29.4% | 0.272 |
| Other indications† | 38 | 5.3% | 12 | 0% | 26 | 7.7% | 1.000 |
| Surgical category | |||||||
| Elective surgery | 703 | 6.1% | 216 | 9.7% | 487 | 4.5% | 0.008 |
| Emergency surgery | 197 | 24.4% | 84 | 23.8% | 113 | 24.8% | 0.875 |
| Surgical site | |||||||
| Supratentorial | 515 | 14.6% | 185 | 17.3% | 330 | 13.0% | 0.188 |
| Infratentorial | 385 | 4.2% | 115 | 7.8% | 270 | 2.6% | 0.025 |
| Contamination class | |||||||
| Clean | 815 | 9.0% | 263 | 11.4% | 552 | 7.8% | 0.091 |
| Clean-contaminant | 85 | 21.2% | 37 | 29.7% | 48 | 14.6% | 0.090 |
Other tumors included neuronal and mixed neuronal-glial tumor, choroid plexus tumor, lymphomas, tumors of the pineal region, melanocytic tumors and germ cell tumors; .